Parametric Portfolio Associates’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $241K | Sell |
80,997
-8,341
| -9% | -$24.8K | ﹤0.01% | 3372 |
|
|
2021
Q4 | $401K | Sell |
89,338
-1,268
| -1% | -$5.69K | ﹤0.01% | 3153 |
|
|
2021
Q3 | $440K | Buy |
90,606
+3,163
| +4% | +$15.4K | ﹤0.01% | 3158 |
|
|
2021
Q2 | $596K | Sell |
87,443
-962
| -1% | -$6.56K | ﹤0.01% | 3008 |
|
|
2021
Q1 | $624K | Sell |
88,405
-3,148
| -3% | -$22.2K | ﹤0.01% | 3390 |
|
|
2020
Q4 | $573K | Sell |
91,553
-1,823
| -2% | -$11.4K | ﹤0.01% | 3319 |
|
|
2020
Q3 | $505K | Sell |
93,376
-4,595
| -5% | -$24.9K | ﹤0.01% | 3276 |
|
|
2020
Q2 | $511K | Sell |
97,971
-31,931
| -25% | -$167K | ﹤0.01% | 3267 |
|
|
2020
Q1 | $409K | Sell |
129,902
-13,094
| -9% | -$41.2K | ﹤0.01% | 3271 |
|
|
2019
Q4 | $576K | Sell |
142,996
-100,627
| -41% | -$405K | ﹤0.01% | 3315 |
|
|
2019
Q3 | $1.05M | Buy |
243,623
+78,175
| +47% | +$338K | ﹤0.01% | 3000 |
|
|
2019
Q2 | $660K | Buy |
165,448
+94,096
| +132% | +$375K | ﹤0.01% | 3251 |
|
|
2019
Q1 | $382K | Buy |
71,352
+29,456
| +70% | +$158K | ﹤0.01% | 3460 |
|
|
2018
Q4 | $215K | Buy |
41,896
+22,601
| +117% | +$116K | ﹤0.01% | 3636 |
|
|
2018
Q3 | $187K | Buy |
19,295
+4,471
| +30% | +$43.3K | ﹤0.01% | 3776 |
|
|
2018
Q2 | $151K | Sell |
14,824
-6,007
| -29% | -$61.2K | ﹤0.01% | 3754 |
|
|
2018
Q1 | $271K | Sell |
20,831
-42,734
| -67% | -$556K | ﹤0.01% | 3609 |
|
|
2017
Q4 | $1.14M | Buy |
63,565
+9,988
| +19% | +$179K | ﹤0.01% | 2950 |
|
|
2017
Q3 | $1.35M | Sell |
53,577
-18,916
| -26% | -$475K | ﹤0.01% | 2853 |
|
|
2017
Q2 | $1.75M | Buy |
+72,493
| New | +$1.75M | ﹤0.01% | 2638 |
|
|
2014
Q2 | – | Sell |
-1,225
| Closed | -$45K | – | 3808 |
|
|
2014
Q1 | $45K | Sell |
1,225
-32
| -3% | -$1.18K | ﹤0.01% | 3787 |
|
|
2013
Q4 | $51K | Buy |
1,257
+13
| +1% | +$527 | ﹤0.01% | 3776 |
|
|
2013
Q3 | $47K | Sell |
1,244
-61
| -5% | -$2.31K | ﹤0.01% | 3778 |
|
|
2013
Q2 | $47K | Buy |
+1,305
| New | +$47K | ﹤0.01% | 3665 |
|